Core One Labs Inc. is a Canada-based life sciences and biotechnology company. The Company is focused on research, development, and production of biologically synthesized (biosynthesized) current Good Manufacturing Practice (cGMP) API grade psychedelic compounds, as well as the advancement of psychedelic assisted modalities for the treatment of various mental health and neurological disorders. It has developed a thin film oral strip (the technology), which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining bioavailability. It focuses on further developing and applying the technology to psychedelic compounds, such as psilocybin. The Company is developing a pipeline of cGMP psychedelic compounds for the furtherance of mental health and neurological disorders research. The Company also holds an interest in medical clinics, which maintain a combined database of over 275,000 patients.